Pediatrics Doctors in Kennebunk, ME Accepting Medicare

5 Pediatrics doctors found. Showing 1 - 5

Lisa Gouldsbrough, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 3 Shape Drive, 2nd Floor, Kennebunk, ME 04043 Phone: 207-467-8930    Fax: 467-985-8459

Christopher Rogers, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 3 Shape Dr, Kennebunk, ME 04043 Phone: 207-467-8930

Dr. Barry Hugo, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 4 Shape Dr, Kennebunk, ME 04043 Phone: 207-467-8955    Fax: 207-467-8959

Donald R Burgess, M.D. Pediatrics - Adolescent Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Shape Dr, Kennebunk, ME 04043 Phone: 207-467-8983    Fax: 207-467-8981

Dr. Deirdre Burns Mondor, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3 Shape Dr, Kennebunk, ME 04043 Phone: 207-467-8930

News Archive

'Secret bill writing' and Washington rumors are issues in health debate

Transparency in the legislative process is on the decline, The Associated Press reports. "Democrats are refusing to open to the public the end-stage negotiations on how the government is going to change the delivery of health care. And it's not just on the high-profile health care bill; the trend on much legislation is to shut the door and keep the minority party, cable TV and other media on the outside."

Clinton's speech prioritizing creation of 'Aids-free generation' may shape future of U.S. global health strategy, analysts say

U.S. Secretary of State Hillary Clinton's November 8 speech at the NIH, in which she called for the creation of an "AIDS-free generation" through the use of combination prevention strategies, "could be more than just political lip-service: it may also shape the next several years of U.S. global health programming and funding, analysts say," PlusNews reports.

New drug delivered through skin effective in treatment of breast cancer

A drug that has proven effective in the prevention and treatment of breast cancer, but with serious side-effects, may be delivered effectively through the skin using a new topical drug-delivery system.

Study provides insights on liver injury in men taking body building supplements

In a study reported in Alimentary Pharmacology & Therapeutics, 44 men with liver injury, attributed to over-the-counter bodybuilding supplements, experienced a uniform and distinctive pattern of signs and symptoms that were often prolonged, difficult to treat, and accompanied by disability and weight loss.

Innate Therapeutics initiates MIS416 Phase 2a clinical study in patients with progressive multiple sclerosis

Innate Therapeutics today announced that the company has begun treating patients in a Phase 2a clinical study of its lead molecule, MIS416, in patients with progressive multiple sclerosis (MS).

Read more Medical News

› Verified 7 days ago